These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22372200)

  • 21. [Mastocytosis, classification, biological diagnosis and therapy].
    Arock M
    Ann Biol Clin (Paris); 2004; 62(6):657-69. PubMed ID: 15563424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonal mast cell disease not meeting WHO criteria for diagnosis of mastocytosis: clinicopathologic features and comparison with indolent mastocytosis.
    Pardanani A; Chen D; Abdelrahman RA; Reichard KK; Zblewski D; Wood AJ; McClure RF; Butterfield JH; Hanson CA; Tefferi A
    Leukemia; 2013 Oct; 27(10):2091-4. PubMed ID: 23896642
    [No Abstract]   [Full Text] [Related]  

  • 23. Bone Marrow Expression of Mast Cell Disorders.
    Sánchez-Muñoz L; Henriques AF; Alvarez-Twose I; Matito A
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):379-395. PubMed ID: 30007458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. c-Kit and c-kit mutations in mastocytosis and other hematological diseases.
    Boissan M; Feger F; Guillosson JJ; Arock M
    J Leukoc Biol; 2000 Feb; 67(2):135-48. PubMed ID: 10670573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunophenotypic characterization of bone marrow mast cells in mastocytosis and other mast cell disorders.
    Sánchez-Muñoz L; Teodósio C; Morgado JM; Escribano L
    Methods Cell Biol; 2011; 103():333-59. PubMed ID: 21722810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and classification of mastocytosis in non-specialized versus reference centres: a Spanish Network on Mastocytosis (REMA) study on 122 patients.
    Sánchez-Muñoz L; Morgado JM; Álvarez-Twose I; Matito A; Garcia-Montero AC; Teodosio C; Jara-Acevedo M; Mayado A; Mollejo M; Caldas C; González de Olano D; Escribano L; Orfao A
    Br J Haematol; 2016 Jan; 172(1):56-63. PubMed ID: 26456532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic criteria and classification of mastocytosis: a consensus proposal.
    Valent P; Horny HP; Escribano L; Longley BJ; Li CY; Schwartz LB; Marone G; Nuñez R; Akin C; Sotlar K; Sperr WR; Wolff K; Brunning RD; Parwaresch RM; Austen KF; Lennert K; Metcalfe DD; Vardiman JW; Bennett JM
    Leuk Res; 2001 Jul; 25(7):603-25. PubMed ID: 11377686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in the World Health Organization 2016 classification of myeloid neoplasms everyone should know.
    Hasserjian RP
    Curr Opin Hematol; 2018 Mar; 25(2):120-128. PubMed ID: 29256927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical variability in two cases of systemic mastocytosis].
    Bazan-Socha S; Rudzki Z; Maciejewicz J; Witkoś T; Szczeklik A
    Pol Arch Med Wewn; 2001 Apr; 105(4):311-5. PubMed ID: 11761803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Towards better understanding of hematolymphoid malignancies--based on the WHO-2008 classification: summary].
    Tohyama K
    Rinsho Byori; 2011 May; 59(5):502-3. PubMed ID: 21706866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flow cytometry in mastocytosis: utility as a diagnostic and prognostic tool.
    Sánchez-Muñoz L; Teodosio C; Morgado JM; Perbellini O; Mayado A; Alvarez-Twose I; Matito A; Jara-Acevedo M; García-Montero AC; Orfao A; Escribano L
    Immunol Allergy Clin North Am; 2014 May; 34(2):297-313. PubMed ID: 24745675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An unexpected association of hematologic malignancies.
    Athanase N; Frébet E
    Blood; 2018 Oct; 132(14):1545. PubMed ID: 30287471
    [No Abstract]   [Full Text] [Related]  

  • 33. Introduction to a review series: the 2016 revision of the WHO classification of tumors of hematopoietic and lymphoid tissues.
    Cazzola M
    Blood; 2016 May; 127(20):2361-4. PubMed ID: 27069255
    [No Abstract]   [Full Text] [Related]  

  • 34. Molecular Pathology: Prognostic and Diagnostic Genomic Markers for Myeloid Neoplasms.
    Kuo FC
    Surg Pathol Clin; 2016 Sep; 9(3):475-88. PubMed ID: 27523973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone marrow disorders: recent advances, part I. Introduction.
    Torlakovic EE; Hyjek E; Butany J
    Semin Diagn Pathol; 2011 Nov; 28(4):257. PubMed ID: 22195403
    [No Abstract]   [Full Text] [Related]  

  • 36. [Emerging Technologies Support the Molecular Basis of the WHO Classification of Hematopoietic Neoplasms].
    Miyachi H
    Rinsho Byori; 2014 Nov; 62(11):1056-64. PubMed ID: 27509721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the WHO criteria for the classification of patients with mastocytosis.
    Sánchez-Muñoz L; Alvarez-Twose I; García-Montero AC; Teodosio C; Jara-Acevedo M; Pedreira CE; Matito A; Morgado JM; Sánchez ML; Mollejo M; Gonzalez-de-Olano D; Orfao A; Escribano L
    Mod Pathol; 2011 Sep; 24(9):1157-68. PubMed ID: 21552214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis.
    Escribano L; Díaz-Agustín B; Bellas C; Navalón R; Nuñez R; Sperr WR; Schernthaner GH; Valent P; Orfao A
    Leuk Res; 2001 Jul; 25(7):563-70. PubMed ID: 11377681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunophenotyping of acute leukemia: utility of CD45 for blast cell identification.
    Vial JP; Lacombe F
    Methods Cell Biol; 2001; 64():343-58. PubMed ID: 11070847
    [No Abstract]   [Full Text] [Related]  

  • 40. [Mastocytosis: when should it be considered?].
    Comte-Perret S; Bart PA; Spertini F; Leimgruber A
    Rev Med Suisse; 2009 Apr; 5(199):837-42. PubMed ID: 19441750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.